After more than 4 years of preparation, on May 6, 2022, the IPO of Red Star Meiling was rejected. This means that the company missed the first share of A-share goat milk.
According to the results of the review meeting of the GEM Listing Committee, the main points of doubts of the regulatory authorities are the 14 million yuan intermediary loan of Red Star Meiling, and the related issues of the original largest customer Wuxi Shede Biotechnology Co., Ltd. (hereinafter referred to as Shede Bio).
How will this IPO be affected by Red Star Meiling? Dairy analyst Song Liang said in an interview with reporters on WeChat that Red Star Meiling has been preparing for a long time in order to sprint to the market. Does this mean that the company’s original development plan may be interrupted, and future development may face some difficulties.
Copyright Notice
1This article is an original work of “Daily Economic News”.
2
Without the authorization of “Daily Economic News”, it may not be used in any way, including but not limited to reprinting, excerpting, copying or creating mirror images, etc. Violators will be held accountable.
3Copyright cooperation telephone: 021-60900099.